The US Justice Department sued Walmart over its role in the opioid crisis, alleging irresponsible handling of orders, wrongly filling thousands of prescriptions, and ignoring warning signs about problem orders to boost sales.
Up to billions of dollars in penalties could be sought in the litigation that followed a multi-year investigation.
According to Jeffrey Bossert Clark, acting head of the Justice Department's civil division, Walmart had the responsibility and the means to help prevent the diversion of prescription opioids but instead did the opposite by filling thousands of invalid prescriptions and failing to report suspicious opioid orders.
The government lawsuit said Walmart managers enormously pressured pharmacists to fill prescriptions and that it withheld the information from pharmacists on data on invalid controlled-substance prescriptions.
Walmart claimed the charges were baseless and accused US authorities of shifting blame from the Drug Enforcement Administration's failures in keeping bad doctors from prescribing opioids. It added that the complaint was "riddled with factual inaccuracies."
According to the Centers for Disease Control and Prevention, nearly 450,000 Americans died between 1999 and 2018 from overdoses due to prescription and illegal opioids.


CK Hutchison Seeks $1.5 Billion From Panama Over Canal Ports
SK Hynix Shares Surge on Record $28.6 Billion Buyback
Alibaba Sells Lingxi Games for Over $1.5 Billion Amid AI Push
Moderna Short Sellers Hit With $4.8 Billion Loss as Stock Soars
OpenAI Tightens AI Safety Monitoring After Security Incidents
Goldman Sachs Names 9 Top Japanese Semiconductor and Electronics Stocks
Unitree Robotics Shares Soar Over 600% in Shanghai Market Debut
Sun Pharma Wins U.S. Appeal in Pfizer Lipitor Antitrust Case
Anthropic Eyes $10B-Plus Credit Line Ahead of Potential IPO
Schott Pharma Stock Rises as Barclays Upgrades Rating on Growth Outlook
Moody’s Upgrades Vodafone Hybrid Debt Ratings to Baa3
AstraZeneca Halts Phase III Volrustomig Lung Cancer Trial After Efficacy Setback
Shein Targets $26B-$27B Valuation for Hong Kong IPO
Hermès Stock Downgraded by RBC as Luxury Growth Premium Narrows
Toyota, Honda Shares Rise on Possible U.S.-Canada Auto Tariff Cut
BofA Sees Micron EPS Topping $230 by 2030, Backs Major Stock Upside 



